Cervical Cancer Screening in Women With Systemic Lupus Erythematosus

To determine rates of cervical cancer screening and associated abnormal results in women with systemic lupus erythematosus (SLE).

[1]  S. Kobrin,et al.  Exacerbating disparities?: Cervical cancer screening and HPV vaccination. , 2019, Preventive medicine.

[2]  Chang-Youh Tsai,et al.  Risk of severe herpes simplex virus infection in systemic lupus erythematosus: analysis of epidemiology and risk factors analysis in Taiwan , 2019, Annals of the rheumatic diseases.

[3]  Kathy L. MacLaughlin,et al.  Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection , 2019, Journal of lower genital tract disease.

[4]  Kathy L. MacLaughlin,et al.  Trends Over Time in Pap and Pap-HPV Cotesting for Cervical Cancer Screening. , 2019, Journal of women's health.

[5]  E. Bae,et al.  Systemic lupus erythematosus is a risk factor for cancer: a nationwide population-based study in Korea , 2019, Lupus.

[6]  B. Graubard,et al.  Patterns and Trends in Cancer Screening in the United States , 2018, Preventing chronic disease.

[7]  M. Suarez‐Almazor,et al.  Low Rate of Cervical Cancer Screening among Women with Hematologic Malignancies after Stem Cell Transplant. , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[8]  E. Flagg,et al.  Assessment of trends in cervical cancer screening rates using healthcare claims data: United States, 2003–2014 , 2018, Preventive medicine reports.

[9]  D. Solomon,et al.  Risk of high-grade cervical dysplasia and cervical cancer in women with systemic lupus erythematosus receiving immunosuppressive drugs , 2017, Lupus.

[10]  J. Denny,et al.  Developing Electronic Health Record Algorithms That Accurately Identify Patients With Systemic Lupus Erythematosus , 2017, Arthritis care & research.

[11]  M. García-Carrasco,et al.  Incidence of cervical human papillomavirus infection in systemic lupus erythematosus women , 2017, Lupus.

[12]  J. Askling,et al.  Cervical neoplasia in systemic lupus erythematosus: a nationwide study , 2016, Rheumatology.

[13]  A. Raposo,et al.  Human papillomavirus infection and cervical lesions in rheumatic diseases: a systematic review. , 2016, Acta reumatologica portuguesa.

[14]  D. Gladman,et al.  Cancer risk in systemic lupus: an updated international multi-centre cohort study. , 2013, Journal of autoimmunity.

[15]  J. Sánchez-Hernández,et al.  Cervical human papillomavirus infection in Mexican women with systemic lupus erythematosus or rheumatoid arthritis , 2012, Lupus.

[16]  L. Dreyer,et al.  High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort. , 2011, Arthritis and rheumatism.

[17]  S. Bombardieri,et al.  [Adherence to cervical cancer screening in an Italian SLE cohort]. , 2011, Reumatismo.

[18]  S. Ho,et al.  Risk factors for squamous intraepithelial lesions in systemic lupus erythematosus: A prospective cohort study , 2011, Arthritis care & research.

[19]  E. Klumb,et al.  Is Higher Prevalence of Cervical Intraepithelial Neoplasia in Women With Lupus Due to Immunosuppression? , 2010, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[20]  G. Hughes,et al.  High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients. , 2007, Arthritis and rheumatism.

[21]  P. Chan,et al.  Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection. , 2004, Arthritis and rheumatism.

[22]  J. Herman.  Health , 1996, Annals of Internal Medicine.

[23]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.